期刊文献+

强化胰岛素治疗脓毒症患者应激性高血糖疗效观察 被引量:6

下载PDF
导出
摘要 脓毒症患者易于出现高能量消耗、高分解代谢等代谢紊乱。应激性高血糖是指机体受创伤后体内激素失衡引起反应性血糖升高,高血糖是增加脓毒症病死率原因之一 。笔者对96例脓毒症患者进行随机对照研究,以观察强化胰岛素控制脓毒症患者血糖可否改善其预后。
作者 刘清敏
出处 《天津医药》 CAS 北大核心 2009年第9期790-791,共2页 Tianjin Medical Journal
  • 相关文献

参考文献7

  • 1姚咏明,盛志勇,林洪远,柴家科.脓毒症定义及诊断的新认识[J].中国危重病急救医学,2004,16(6):321-324. 被引量:307
  • 2Bone RC, Balk RA, Cerra FB, et al. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepis. The ACCP/SCCM consensus conference committee. American college of Chest Physicians Society of Critiaal Care Medicine[J].Chest, 1992,101(6):1644-1655.
  • 3Vanden Berghe G, Woutes P, Weekers F, et al.lntensive insulin therapy in critically ill patients [J]. N Engl J Med,2001,34 (5): 1359- 1367.
  • 4Gao F, Gao E,Yue TL,et al.Nitric oxide mediates the antiapoptotic Effect of insulin in myocardial ischemia-reperfusion:the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation[J]. Circulation,2002,105(12): 1497-1502.
  • 5Hansen TK,Thiel S,Wouters PJ,et al.Intensive insulin therapy exert Antiinflammatory effects in critically ill patients and counteracts the Adverse effect of low mannose-binding lectin levels [J]. J Clin Endocrinol Metab,2003,88(3): 1082-1088.
  • 6虞文魁,李维勤,王晓东,燕晓雯,祁晓平,李宁,黎介寿.胰岛素严格控制血糖对脓毒症患者的影响及其机理的初步探讨[J].中华外科杂志,2005,43(1):29-32. 被引量:47
  • 7姚咏明,孟海东.脓毒症高血糖与胰岛素强化治疗策略[J].中国危重病急救医学,2006,18(2):68-70. 被引量:84

二级参考文献9

  • 1Dellinger RP, Carlet JIM, Masur H, et al. Surviving Sepsis Campaign Management Guidelines Committee. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med, 2004, 32:858-873.
  • 2Tsai MH, Peng YS, Lien JM, et al. Multiple organ system failure in critically Ill cirrhotic patients. A comparison of two multiple organ dysfunction/failure scoring systems. Digestion, 2004, 69:190-200.
  • 3Das UN. Insulin and the critically ill. Crit Care, 2002, 6:262-263.
  • 4Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab, 2003,88:1082-1088.
  • 5Yu WK, Li WQ, Li N, et al. Mononuclear histocompatibility leukocyte antigen-DR expression in the early phase of acute pancreatitis. Pancreatology, 2004, 27,4:233-243.
  • 6Tschaikowsky K, Hedwig-Geissing M, Schiele A, et al. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompathtibility leukocyte antigen-DR expression, procalctonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med, 2002,30:1015-1023.
  • 7van den Berghe G, Wouters P, Weekers F,et al. Intensive insulin therapy in critically ill. N Engl J Med, 2001, 345:1359-1367.
  • 8Netea MG, van der Meer JW, Kullberg BJ. Sepsis-theory and therapies. N Engl J Med, 2003, 348:1600-1602.
  • 9American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Crit Care Med, 1992,20:864-874.

共引文献424

同被引文献54

引证文献6

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部